Shigellosis cases are estimated at 164.7 million worldwide. Approximately 98% of cases occur in developing countries development and 2% in industrialised countries, where they cause about 600,000 deaths per year. Shigellosis is one of the leading causes of infant mortality in developing countries development. Sixty-nine percent of deaths occur in children under 5 years of age.
Treatment and vaccination
Antibiotic treatment and fluid replacement are effective. There is no vaccine. Preventive measures focus on good food hygiene, hand washing and proper waste management. Some of these treatment and prevention measures are complex to implement in developing countries development. For this reason, and given the high propensity for large epidemics, priority has been given to development for effective vaccines to combat it.
Team researcher Bacterial pathologies. Shigellosis-ETEC
Carlos Gamazo (PhD)
+34 948 42 56 00 Extension: 806251View CV "View Carlos Gamazo's CV (PhD)".
Juan Manuel Irache (PhD)
+34 948 42 56 00 Extension: 806478
+34 425600 Extension: 806205
The most important publications of the last few years can be viewed via PubMed (click here).